Physician profile
Angela D Pellant
NPI 1780626358
$567.38
in general payments reported to CMS, 2019-2025
10 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.20 · 2023: $86.45 · 2024: $202 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $136.72 | 2024-2025 | |
| Pfizer INC. | $129.05 | 2024-2025 | |
| Dexcom, INC. | $75.55 | 2024-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $75.49 | 2023-2025 | Lumenis Pulse 120h, General - Pain Management |
| Abbvie INC. | $49.74 | 2021-2023 | |
| Astellas Pharma US INC | $27.81 | 2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $24.45 | 2025 | Eliquis |
| Medtronic, INC. | $17.67 | 2025 | Minimed 780g |
| Edwards Lifesciences Corporation | $17.27 | 2024 | Sapien 3 Ultra Resilia |
| Vertex Pharmaceuticals Incorporated | $13.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pellant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.